1 active not recruiting, 1 completed, 1 recruiting. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Active not recruiting 1, Completed 1, Recruiting 1 |
| Phase 2 | 1 | Recruiting 1 |
Follow Prostate CA: new trials by email Literature Review of Prostate CA trials Research Report on Prostate CA
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Research on the Application of 68Ga-PSMA-CYC PET Imaging in the Diagnosis, Staging, and Restaging of Prostate Cancer 68Ga-PSMA-CYC, CYC - Prostate CA | Phase 1 / Phase 2 | Recruiting | First Affiliated Hospital of Fujian Medical University | 40 | 2025-05-15 | 2025-07-09 |
| Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer Darolutamide, Relugolix, Radical Prostatectomy - Prostate CA, Prostate Cancer (Adenocarcinoma) | Phase 1 | Active not recruiting | AdventHealth | 32 | 2024-10-22 | 2026-11-10 |
| Research on PSMA-Targeted Intraoperative Fluorescent Imaging Agents 0.01mg/kg DGPR1008 Injection Dose Group 1 (n=6), 0.02mg/kg DGPR1008 Injection Dose Group 2 (n=6), 0.04mg/kg DGPR1008 Injection Dose Group 3 (n=6) - Prostate Cancer Patients Undergoing Radical Prostatectomy, Prostate CA | Phase 1 | Completed | Haitao Niu, MD | 32 | 2024-06-24 | 2025-08-03 |
Prostatic Neoplasms (2) · Adenocarcinoma (1)
Genital Diseases (2) · Genital Diseases, Male (2) · Genital Neoplasms, Male (2) · Male Urogenital Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Prostatic Diseases (2) · Urogenital Diseases (2) · Urogenital Neoplasms (2) · Carcinoma (1) · Neoplasms by Histologic Type (1) · Neoplasms, Glandular and Epithelial (1)
darolutamide (1) · relugolix (1)
AdventHealth (1) · First Affiliated Hospital of Fujian Medical University (1) · Haitao Niu, MD (1)
China (2) · United States (1)
Weibing Miao, MD (1)